|
1
|
Aparicio T, Zaanan A, Svrcek M,
Laurent-Puig P, Carrere N, Manfredi S, Locher C and Afchain P:
Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis
and treatment. Dig Liver Dis. 46:97–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dabaja BS, Suki D, Pro B, Bonnen M and
Ajani J: Adenocarcinoma of the small bowel: Presentation,
prognostic factors, and outcome of 217 patients. Cancer.
101:518–526. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dangles-Marie V, Pocard M, Richon S,
Weiswald LB, Assayag F, Saulnier P, Judde JG, Janneau JL, Auger N,
Validire P, et al: Establishment of human colon cancer cell lines
from fresh tumors versus xenografts: comparison of success rate and
cell line features. Cancer Res. 67:398–407. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kawai S, Takagi Y, Kaneko S and Kurosawa
T: Effect of three types of mixed anesthetic agents alternate to
ketamine in mice. Exp Anim. 60:481–487. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nakayama T, Saito R, Furuya S, Shoda K,
Maruyma S, Takiguchi K, Shiraishi K, Akaike H, Kawaguchi Y, Amemiya
H, et al: Inhibition of cancer cell-platelet adhesion as a
promising therapeutic target for preventing peritoneal
dissemination of gastric cancer. Oncol Lett. 26:5382023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lorenzi PL, Reinhold WC, Varma S,
Hutchinson AA, Pommier Y, Chanock SJ and Weinstein JN: DNA
fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther.
8:713–724. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu M, Selvaraj SK, Liang-Chu MM, Aghajani
S, Busse M, Yuan J, Lee G, Peale F, Klijn C, Bourgon R, et al: A
resource for cell line authentication, annotation and quality
control. Nature. 520:307–311. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Medico E, Russo M, Picco G, Cancelliere C,
Valtorta E, Corti G, Buscarino M, Isella C, Lamba S, Martinoglio B,
et al: The molecular landscape of colorectal cancer cell lines
unveils clinically actionable kinase targets. Nat Commun.
6:70022015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ono K, Satoh M, Yoshida T, Ozawa Y, Kohara
A, Takeuchi M, Mizusawa H and Sawada H: Species identification of
animal cells by nested PCR targeted to mitochondrial DNA. In Vitro
Cell Dev Biol Anim. 43:168–175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Natomi H, Sugano K, Iwamori M, Saito E,
Kubota S, Kondo Y, Osawa N and Takaku F: Production of CA19-9 in
cultured human gastric cancer cell lines. Nihon Shokakibyo Gakkai
Zasshi. 85:236–242. 1988.PubMed/NCBI
|
|
11
|
Suzuki H, Hirata Y, Suzuki N, Ihara S,
Sakitani K, Kobayashi Y, Kinoshita H, Hayakawa Y, Yamada A, Watabe
H, et al: Characterization of a new small bowel adenocarcinoma cell
line and screening of anti-cancer drug against small bowel
adenocarcinoma. Am J Pathol. 185:550–562. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Adam L, San Lucas FA, Fowler R, Yu Y, Wu
W, Liu Y, Wang H, Menter D, Tetzlaff MT, Ensor J Jr, et al: DNA
sequencing of small bowel adenocarcinomas identifies targetable
recurrent mutations in the ERBB2 signaling pathway. Clin Cancer
Res. 25:641–651. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamano T, Kubo S and Tomita N: A
patient-derived xenograft and a cell line derived from it form a
useful preclinical model for small bowel adenocarcinoma. Cancer
Med. 9:3337–3343. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Laforest A, Aparicio T, Zaanan A, Silva
FP, Didelot A, Desbeaux A, Le Corre D, Benhaim L, Pallier K, Aust
D, et al: ERBB2 gene as a potential therapeutic target in small
bowel adenocarcinoma. Eur J Cancer. 50:1740–1746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schrock AB, Devoe CE, McWilliams R, Sun J,
Aparicio T, Stephens PJ, Ross JS, Wilson R, Miller VA, Ali SM and
Overman MJ: Genomic profiling of small-bowel adenocarcinoma. JAMA
Oncol. 3:1546–1553. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tatsuguchi A, Yamada T, Ueda K, Furuki H,
Hoshimoto A, Nishimoto T, Omori J, Akimoto N, Gudis K, Tanaka S, et
al: Genetic analysis of Japanese patients with small bowel
adenocarcinoma using next-generation sequencing. BMC Cancer.
22:7232022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ojima H, Yoshikawa D, Ino Y, Shimizu H,
Miyamoto M, Kokubu A, Hiraoka N, Morofuji N, Kondo T, Onaya H, et
al: Establishment of six new human biliary tract carcinoma cell
lines and identification of MAGEH1 as a candidate biomarker for
predicting the efficacy of gemcitabine treatment. Cancer Sci.
101:882–888. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Damhofer H, Ebbing EA, Steins A, Welling
L, Tol JA, Krishnadath KK, van Leusden T, van de Vijver MJ,
Besselink MG, Busch OR, et al: Establishment of patient-derived
xenograft models and cell lines for malignancies of the upper
gastrointestinal tract. J Transl Med. 13:1152015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pham K, Delitto D, Knowlton AE, Hartlage
ER, Madhavan R, Gonzalo DH, Thomas RM, Behrns KE, George TJ Jr,
Hughes SJ, et al: Isolation of pancreatic cancer cells from a
patient-derived xenograft model allows for practical expansion and
preserved heterogeneity in culture. Am J Pathol. 186:1537–1546.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
De Thaye E, Van de Vijver K, Van der
Meulen J, Taminau J, Wagemans G, Denys H, Van Dorpe J, Berx G,
Ceelen W, Van Bocxlaer J and Wever OD: Establishment and
characterization of a cell line and patient-derived xenograft (PDX)
from peritoneal metastasis of low-grade serous ovarian carcinoma.
Sci Rep. 10:66882020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zaanan A, Costes L, Gauthier M, Malka D,
Locher C, Mitry E, Tougeron D, Lecomte T, Gornet JM, Sobhani I, et
al: Chemotherapy of advanced small-bowel adenocarcinoma: A
multicenter AGEO study. Ann Oncol. 21:1786–1793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li N, Shen W, Deng W, Yang H, Ma Y, Bie L,
Wei C and Luo S: Clinical features and the efficacy of adjuvant
chemotherapy in resectable small bowel adenocarcinoma: a
single-center, long-term analysis. Ann Transl Med. 8:9492020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matsuzawa K, Itabashi K, Matsuzawa S,
Tsutsumi O, Hiki Y and Kakita A: A case of large liver cyst with
extraordinally high level of CA19-9 in the serum, CA19-9 and CEA in
the cystic fluid. Nihon Shokakigeka Gakkai Zasshi. 32:2375–2379.
1999.(In Japanese).
|
